Alecensa 150mg Capsules - Origin: Mumbai

Alecensa 150mg Capsules (Alectinib)

Product Description:
Alecensa 150mg Capsules contain Alectinib 150mg, a targeted anti-cancer medicine used for the treatment of ALK-positive Non-Small Cell Lung Cancer (NSCLC) in adult patients. It belongs to the class of tyrosine kinase inhibitors (TKIs) and works by blocking abnormal ALK proteins that promote cancer cell growth and spread.

Key Features:
Contains: Alectinib 150mg
Dosage Form: Oral Capsules
Therapeutic Category: Anti-Cancer / Oncology
Mechanism: ALK (Anaplastic Lymphoma Kinase) Inhibitor
Packaging: As available
Prescription Required

Uses:
Treatment of ALK-positive Non-Small Cell Lung Cancer (NSCLC)
Used in eligible patients as prescribed by oncologists

How It Works:
Alecensa helps slow or stop cancer progression by selectively inhibiting ALK activity, which may reduce tumor growth and support disease management.

Storage:
Store below 30C in a cool, dry place away from direct sunlight.